tiprankstipranks
NOXXON Pharma NV (DE:0N6A)
FRANKFURT:0N6A
Germany Market
Holding DE:0N6A?
Track your performance easily

NOXXON Pharma NV (0N6A) Financial Statements

0 Followers

NOXXON Pharma NV Financial Overview

NOXXON Pharma NV's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; NOXXON Pharma NV is scheduled to report earnings on April 23, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.02M$ 9.48M$ 13.70M$ 10.33M$ 10.70M
Total Assets$ 8.28M$ 9.77M$ 14.04M$ 10.65M$ 10.94M
Total Debt$ ―$ 2.44M$ 45.00K$ 615.00K$ 92.00K
Net Debt$ ―$ -7.04M$ -13.65M$ -9.72M$ -10.61M
Total Liabilities$ 6.06M$ 5.27M$ 4.22M$ 2.96M$ 2.56M
Stockholders Equity$ 2.24M$ 4.51M$ 9.83M$ 7.71M$ 8.39M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

NOXXON Pharma NV Earnings and Revenue History

NOXXON Pharma NV Debt to Assets

NOXXON Pharma NV Cash Flow

NOXXON Pharma NV Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis